Skip to main content

Table 1 Comparison of demographic, atopic features and wheezing frequency according to asthma outcome

From: Utility of basophil activation test for predicting the outcome of wheezing in children: a pilot study

  Non-asthma
(n = 17)
Asthma
(n = 26)
p value*
Sex, n(%)
 Male 7 (63.6) 21 (73.7) > 0.05
 Female 4 (36.4) 6 (22.2)
Age, n(%)
 ≤ 3 years old 8 (72.7) 11 (40.7) > 0.05
 3–5 years old 3 (27.3) 16 (59.3)
History of personal allergic diseases, n(%) 8 (72.7) 20 (74.7) > 0.05
History of family allergic diseases, n(%) 4 (36.4) 16 (59.3) > 0.05
sIgE, n(%) 5 (45.5) 21 (77.8) > 0.05
Systemic glucocorticoid, n(%) 4 (36.4) 5 (18.5) > 0.05
Wheezing frequency, n(%)
 <4 10 (90.9) 9 (33.3) < 0.01
 ≥ 4 1 (9.1) 27 (66.7) < 0.01
  1. Allergic disease: AR, AD and asthma; * Pearson Chi-Square test